Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case

J Nephrol. 2011 Jul-Aug;24(4):530-4. doi: 10.5301/JN.2011.8343.

Abstract

An updated review of cases of reactivated visceral leishmaniasis (VL) in transplant patients is presented, with a new report of a kidney transplant patient who had VL caused by reactivation of a dormant infection contracted 21 years previously. Close to the time of disease reactivation, the patient had a primary varicella-zoster infection.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Amphotericin B / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • Graft Rejection / prevention & control
  • Humans
  • Immunocompromised Host
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / immunology
  • Leishmania*
  • Leishmaniasis, Visceral / diagnosis*
  • Leishmaniasis, Visceral / drug therapy
  • Leishmaniasis, Visceral / etiology
  • Male
  • Middle Aged
  • Opportunistic Infections / parasitology*

Substances

  • Antiprotozoal Agents
  • Amphotericin B